WC

Whalehaven Capital Fund

North America, Ontario, Canada, Toronto

Description

Whalehaven Capital Fund is a hedge fund that caters to companies in the U.S. and Canadian small cap marketplace.

Investor Profile

Whalehaven Capital Fund has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (50%)
  • Series Unknown (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Pharmaceutical
  • Therapeutics
  • Health Care
  • Medical
  • Information Technology
  • Management Consulting
  • Software
  • Supply Chain Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Whalehaven Capital Fund frequently co-invest with?

Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 3
Northern Rivers Capital Management
North America, Ontario, Canada, Toronto
Co-Investments: 1
LA
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1
InterGroup
Oceania, Auckland, New Zealand, Auckland
Co-Investments: 1
Alpha Capital
North America, Illinois, United States, Chicago
Co-Investments: 4
Heights Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
Midsummer Capital
North America, New York, United States, New York
Co-Investments: 2
Defiance Capital
North America, New York, United States, New York
Co-Investments: 1
ArmaVir Partners
North America, New York, United States, New York
Co-Investments: 2
NV
North America, Illinois, United States, Deerfield
Co-Investments: 1

What are some of recent deals done by Whalehaven Capital Fund?

Sevion Therapeutics

San Diego, California, United States

Sevion is a biopharmaceutical company which discovers and develops entirely new therapeutic classes for the treatment of cancer.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityMar 29, 2010
Amount Raised: $11,500,000
CEL-SCI

Vienna, Virginia, United States

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

BiotechnologyHealth CareMedical
Post Ipo EquityAug 20, 2009
Amount Raised: $4,400,000
Somanta Pharmaceuticals

Irvine, California, United States

Somanta Pharmaceuticals is a development-stage biopharmaceutical company manufacturing therapeutic drugs for the treatment of cancer.

Biotechnology
Series UnknownJan 31, 2006
Amount Raised: $3,670,000
BravoSolution

Malvern, Pennsylvania, United States

BravoSolution offers software, practice innovation and expertise solutions to companies to align supply management with their objectives.

Information TechnologyManagement ConsultingSoftwareSupply Chain Management
Series UnknownAug 16, 2005
Amount Raised: $6,500,000